IPP Bureau
Roche wins CE mark for Alzheimer’s blood test that could transform early diagnosis
By IPP Bureau - May 13, 2026
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
Breakthrough wearable heart failure therapy enables earlier hospital discharge: UK trial
By IPP Bureau - May 13, 2026
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy
By IPP Bureau - May 13, 2026
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
COMAU and Omron Robotics forge global automation alliance to accelerate smart manufacturing
By IPP Bureau - May 12, 2026
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Merck Foundation reaffirms 14-year commitment to women empowerment
By IPP Bureau - May 12, 2026
Initiatives include scholarships, STEM initiatives, and healthcare capacity-building programmes supporting women and girls across 52 countries
Plus Therapeutics subsidiary clears key Medicare milestone
By IPP Bureau - May 12, 2026
Paves way for CNS cancer test rollout
P. D. Hinduja Hospital introduces CORI robotic-assisted system for knee and hip replacement
By IPP Bureau - May 12, 2026
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs
By IPP Bureau - May 12, 2026
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
Laser-based framework to precisely control liquid droplets
By IPP Bureau - May 12, 2026
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
FDA okays RIVANNA’s AI-powered Accuro XV ultrasound system
By IPP Bureau - May 12, 2026
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge
By IPP Bureau - May 12, 2026
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
Computational tool ‘Renoir’ to decode cell communication in complex tissues
By IPP Bureau - May 12, 2026
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
Bike rally in Hyderabad promotes thalassemia awareness
By IPP Bureau - May 12, 2026
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
